Is Randomization to Placebo Safe? Risk in Placebo-Controlled Angina Trials: Angina Risk Meta-Analysis

Publisher： Karger

E-ISSN： 1421-9751|120|3|174-181

ISSN： 0008-6312

Source： Cardiology, Vol.120, Iss.3, 2012-01, pp. : 174-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effects of statins on major cerebrovascular events: a multiple-treatments meta-analysis of placebo-controlled and active-comparator trials

By Naci H.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 4, 2013-04 ,pp. : 299-306

Oxford University Press

Access to resources Recommend Favorite

Systematic Review on the Efficacy of Fexofenadine in Seasonal Allergic Rhinitis: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Clinical Trials

By  

International Archives of Allergy and Immunology, Vol. 156, Iss. 1, 2011-03 ,pp. : 1-15

Karger

Access to resources Recommend Favorite

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1034-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sildenafil citrate for erectile dysfunction in men with diabetes and cardiovascular risk factors: a retrospective analysis of pooled data from placebo-controlled trials

By Blonde Lawrence  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2111-2120

Informa Healthcare

Access to resources Recommend Favorite

Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

By  

JOURNAL OF HUMAN NUTRITION & DIETETICS (ELECTRONIC), Vol. 31, Iss. 1, 2018-02 ,pp. : 67-84

John Wiley & Sons Inc

Access to resources Recommend Favorite